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Abstract
Sandﬂy fever viruses (SFVs) cause febrile diseases as well as aseptic meningitis/encephalitis and include serotypes sandﬂy fever Sicilian
virus (SFSV), sandﬂy fever Naples virus (SFNV) and Toscana virus (TOSV). Infections are endemic in the Mediterranean basin and data
on SFV activity in Turkey are limited. In this study, sera from 1533 blood donors from the Ankara, Konya, Eskisehir and Zonguldak
provinces of Turkey were evaluated for SFV exposure by indirect immunoﬂuorescence test (IIFT) and conﬁrmed by virus neutralization
test (VNT). One hundred and two patients with central nervous system (CNS) infections of unknown aetiology were also tested via
IIFT and real-time reverse-transcription PCR for SFV/TOSV. Rate of overall IgG reactivity in IIFT was 32.9% (505/1533) among blood
donors. TOSV exposure was conﬁrmed by VNT in all study regions. Exposure to the recently-identiﬁed serotype sandﬂy fever Turkish
virus, as evaluated by VNT, was revealed in Konya and Ankara. SFNV exposure was identiﬁed in Konya and SFSV was observed to be
present in all regions except Zonguldak. TOSV RNA was detected in 15.7% (16/102) and was accompanied by TOSV IgM in 25% (4/16)
of the patients. Partial L and S sequences suggested that TOSV circulating in Turkey can be grouped into TOSV genotype A strains.
Exposure to TOSV and other SFV serotypes was revealed in blood donors and CNS infections by TOSV were identiﬁed for the ﬁrst
time in Turkey. Infections are observed to be endemic in central Anatolia and should be considered as aetiologic agents in cases/out-
breaks of fever and meningoencephalitis.
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Introduction
Sandﬂy fever viruses (SFV) are arthropod-borne viruses trans-
mitted to humans by the bite of phlebotomine sandﬂies of the
Psychodidae family [1]. They are single stranded RNA viruses,
classiﬁed in the Phlebovirus genus of the Bunyaviridae and
comprise three major serotypes; sandﬂy fever Sicilian virus
(SFSV), sandﬂy fever Naples virus (SFNV) and Toscana virus
(TOSV) [1,2]. SFNV and SFSV serotypes cause a self-limited
febrile condition known as phlebotomus, papatacci or sandﬂy
fever [1,2]. Sandﬂy fever Cyprus virus (SFCV), a variant of the
SFSV serotype, is also responsible for acute febrile diseases
[3]. TOSV displays a distinct neurotropism and causes aseptic
meningoencephalitis in infected individuals [4–6]. In endemic
regions, such as countries in the Mediterranean basin, sandﬂy
fever is common, as revealed by serosurveys, and TOSV infec-
tions account for a high proportion of human aseptic meningi-
tis during the summer months [7–12]. Information about SFV
activity in Turkey, as a country in the endemic region, is lim-
ited [13,14]. In sera collected in 1955, seroprevalence rates of
22% and 62% for SFSV and SFNV, respectively, were reported
in 50 adults from the Mediterranean province of Antalya [13].
In the Aegean region, seroprevalence rates of 0.84% and
13.9% were observed [14]. Ozbel et al. also identiﬁed SFNV
and TOSV activity in two towns (Akbuk and Olukbasi) in the
same region (3rd Balkan Conference of Microbiology Pro-
ceedings; 2003, pp. 152–155). A recent report indicates that
outbreaks of febrile diseases without central nervous system
(CNS) symptoms associated with sandﬂy bites in Izmir
(Aegean coast), Adana (Mediterranean coast) and Ankara
(Central Anatolia) provinces were attributable to SFSV and a
ª2010 The Authors
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE VIROLOGY
novel variant of SFSV, provisionally named sandﬂy fever
Turkish virus (SFTV), was identiﬁed [15]. Nevertheless,
clinical cases of TOSV have not yet been described from
Turkey and the seroepidemiology in the regions affected by
the outbreaks is not known. Therefore, we aimed to assess
SFV exposure in healthy blood donors from central/northern
Anatolia and the role of TOSV and other SFVs in CNS
infections of unidentiﬁed aetiology from central Anatolia.
Materials and Methods
Samples from blood donors
A total of 1533 sera, collected after informed consent
between January and April 2009 from volunteer blood donors
at four major branches of the Turkish Red Crescent Middle
Anatolia Regional Blood Center (in Ankara, Konya, Eskis¸ehir
and Zonguldak, cities of Turkey), were included. The distribu-
tion of sera according to the sampling locations was: Ankara,
884; Konya, 388; Eskisehir, 143; and Zonguldak, 118; this had
been determined according to the population in each area
(Fig. 1). Ankara is the capital and second most densely popu-
lated city in Turkey. Mean age of the study group was 40.7
(range, 23–64; SD, 13.16), with a female percentage of 12.1%.
All participants ﬁlled out a questionnaire to reveal the pres-
ence of risk factors for vector-borne infections. All sera were
transported on dry ice and stored in aliquots at )20C.
Samples from patients
Sera obtained from 102 adult patients with the preliminary
diagnosis of aseptic meningoencephalitis, collected between
April and October 2009, were evaluated retrospectively. The
majority of the patients (98/102; 96%) resided in central Ana-
tolia. The samples, obtained within 2–4 days after the onset
of symptoms, were stored in aliquots at )20 and )80C for
future analysis at the Hacettepe University Hospital Central
Laboratory. Cultures for Mycobacterium tuberculosis and other
causes of bacterial/fungal meningitis, as well as polymerase
chain reaction (PCR) assays for herpes viruses, were nega-
tive. Clinical history and laboratory data of the patients were
retrieved from medical records.
The study was performed after approval from Hacettepe
University Medical Ethics Committee and according to the
blood donation ofﬁcial guidelines of the Turkish Red Cres-
cent Society as approved by the Turkish Ministry of Health.
Detection and conﬁrmation of SFV exposure in blood
donors
Sera from blood donors were evaluated for SFV IgG by a com-
mercial indirect immunoﬂuorescence test (IIFT) (sandﬂy fever
virus IgG Mosaic I; EuroImmun, Luebeck, Germany) that allows
simultaneous detection of four viral serotypes (SFSV, SFNV,
TOSV and SFCV), performed as indicated by the manufacturer.
The virus neutralization tests (VNTs) were performed on
Vero B4 cells, using standard methods [16,17], and described
virus strains (SFSV Oct-85 Sabin, SFNV Oct-85 Sabin and
TOSV ISS.Phl.3) [18] and the novel SFTV isolate [15]. Brieﬂy,
the assays were carried out with serial serum dilutions of
1/10–1/320 and virus strains were used at a ﬁnal concentration
of 100 TCID50. Readout was performed after 72 h of incuba-
tion at 37C and positivity was determined by the lack of cyto-
pathogenic effect above a serum dilution of 1/20.
Evaluation of patient samples
Sera from patients were tested for SFV IgM and IgG by IIFT
(sandﬂy fever virus IgG and IgM Mosaic I) as explained above
and for viral RNA by PCR. RNA was extracted using the
Qiamp viral RNA mini kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s instructions and subjected to
quantitative real-time RT-PCR targeting the S segment of
SFSV, SFNV and TOSV as previously described [18,19]. For
the recently-identiﬁed SFTV, forward (5¢-TCTGAGAACT
GAGCTACAAGTGTTTATTAT-3¢) and reverse (5¢-TTCCC
ATCTCTCTTCTGAAGAGTG-3¢) primers and TaqMan
probe (5¢-FAMAGGTCATAGACAGTATCATGAGAATTGC
TAGGTG-TAMRA-3¢) were employed for the real-time RT-
PCR with the temperature proﬁle: RT at 63C 3 min, activa-
tion at 95C 30 s, and 45 cycles of two-step PCR at 95C 5 s,
60C 15 s [15]. IgM and/or RNA positive sera were inoculated
onto monolayers of Vero B4 cells for virus isolation. S segment
PCR positive samples and inoculated culture supernatants at
day 7 were further subjected to ampliﬁcation via generic
phlebovirus L segment primers (NPhlebo1+, NPhlebo1),
NPhlebo2+ and ATos2)) as described previously [20].
Results
SFV exposure in blood donors
A total of 505 of 1533 samples (32.9%) were reactive in the
IgG IIFT (Table 1). Samples reactive against a single serotype
in the IIFT (46 TOSV, 21 SFSV, 12 SFNV, 7 SFCV positives;
total, 86) and dual positives that included a reactivity against
TOSV (total, 17) were selected for VNT. The most common
dual reactivities observed in the IIFT were for SFSV + SFCV
and TOSC + SFNV (data not shown). Eight sera were
excluded from VNTs due to insufﬁcient amounts. A total of
95 and 74 samples could be evaluated via VNTs for SFSV,
SFNV, TOSV and SFTV (Table 1). In the VNTs, exposure to
more than one serotype (SFSV + SFTV and/or
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SFSV + SFTV + SFNV) was conﬁrmed in eight samples from
Konya and in ﬁve samples from Ankara (total, 13/74; 17.6%).
Distribution of IIFT and VNT results are summarized in
Table 1 and Fig. 1. The highest VNT titers observed were
1:40 for TOSV, 1:160 for SFNV and 1:320 for SFSV and SFTV.
TOSV in aseptic meningitis/encephalitis cases
TOSV RNA was detected in 16 (16/102, 15.7%) sera and
was accompanied by TOSV IgM in four cases (4/16, 25%)
(Table 2). TOSV IgM was observed in seven (7/102, 6.9%)
sera without detectable RNA. Real-time RT-PCR for SFV
serotypes other than TOSV was negative in all samples.
Mean and median TOSV loads determined in the cases were
4.39 · 106 and 2.59 · 107 copies/mL, respectively (range,
48 794–2.31 · 108, Table 2). Attempts at viral isolation from
PCR and/or IgM reactive cases were not successful.
Patient history and clinical progress could be reviewed in
11 out of 16 RT-PCR positive individuals. All persons had
FIG. 1. Map showing the blood donor sam-
pling locations and conﬁrmed SFV exposure
rates according to the region. The total num-
ber of blood donors evaluated by IIFT
between January and April 2009 in each
region is indicated in parentheses. The bars
represent: 1, sandﬂy fever Sicilian virus
(SFSV); 2, sandﬂy fever Naples virus (SFNV);
3, Toscana virus (TOSV); 4, sandﬂy fever
Turkish virus (SFTV). The rates were calcu-
lated according to the total number of sam-
ples evaluated by virus neutralization for each
area (see Table 1 and Materials and methods
for details).
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fever (>37.5C) and headache, but no symptoms or test
results indicating systemic involvement could be demon-
strated and all had been discharged without sequelae
(Table 2).
The S-segment real-time RT-PCR amplicon of patient 4
and a partial L-segment PCR amplicon of patient 7 were
ligated into pCRII plasmid (Invitrogen, Breda, Netherlands)
and successfully sequenced. Phylogenetic analyses of these
sequences were carried out using the MEGA 3 program by
using the Kimura model for nucleotide substitutions and mul-
tiple sequence alignment was performed by CLUSTALW2
(Fig. 2a,b) [21].
TABLE 1. Distribution of IIFT and VNT results according to the study region
SFV IgG IIFT
negative (%)
SFV IgG IIFT positive
Total (%)
VNT conﬁrmedb (positive/total, %)
Single Duala
Triple + all
positivea SFSV SFNV TOSV SFTV
Ankara (n = 884) 701 (79.3) 28 99 56 183 (20.7) 5/34 (14.7) 0/34 (0) 1/34 (2.9) 2/31 (6.4)
Konya (n = 388) 132 (34.1) 36 137 83 256 (65.9) 8/43 (18.6) 5/43 (11.6) 11/43 (25.5) 7/25 (28)
Eskisehir (n = 143) 112 (78.4) 8 13 10 31 (21.6) 1/6 (16.6) 0/6 (0) 1/6 (16.6) 0/6 (0)
Zonguldak (n = 118) 83 (70.4) 14 14 7 35 (29.6) 0/12 (0) 0/12 (0) 1/12 (8.3) 0/12 (0)
Total (n = 1533) 1028 (67.1) 86 263 156 505 (32.9) 14/95 (14.7) 5/95 (5.2) 14/95 (14.7) 9/74 (12.1)
SFV, sandﬂy fever virus; IIFT, indirect immunoﬂuorescence test; VNT, virus neutralization test; SFSV, sandﬂy fever Sicilian virus; SFNV, sandﬂy fever Naples virus; TOSV, Tos-
cana virus; SFTV, sandﬂy fever Turkish virus.
aIncludes any combination of the four SFV serotypes, SFSV, SFNV, TOSV and SFCV (see text for details).
bNinety-ﬁve samples were evaluated for SFSV, SFNV and TOSV; 74 samples were evaluated for SFTV.
TABLE 2. Clinical symptoms and laboratory data of the TOSV real-time RT-PCR positive cases
No.
Age/gender/place
of residence CSF evaluation
Meningitic
symptomsa
Encephalitic
symptomsb
Gastrointestinal
symptomsc
TOSV loadd
(copies/mL) TOSV IgMc
1 35, Male, Ankara Normal + ) ) 1.69 · 105 )
2 51, Male, Konya Pleocytosis,
increased protein
+ + + 8.26 · 106 )
3 19, Female, Ankara Normal + ) ) 6.99 · 106 )
4 43, Female, Ankara n.i. n.i. n.i. n.i. 1.80 · 107 )
5 32, Female, Ankara Pleocytosis + ) ) 2.31 · 108 )
6 35, Female, Ankara Normal + ) + 2.35 · 105 )
7 34, Female, Ankara Increased protein + ) ) 6.24 · 107 )
8 18, Male, Konya n.i. n.i. n.i. n.i. 6.58 · 105 )
9 26, Male, Ankara Pleocytosis, increased
protein and glucose
+ ) ) 8.84 · 106 +
10 29, Female, Ankara Pleocytosis ) + ) 1.94 · 106 +
11 29, Male, Ankara Normal + ) ) 3.47 · 106 )
12 26, Female, Ankara Normal + ) ) 7.94 · 105 +
13 30, Male, Eskisehir Increased protein + ) ) 5.42 · 104 )
14 31, Female, Ankara n.i. n.i. n.i. n.i. 5.04 · 106 +
15 32, Male, Ankara n.i. n.i. n.i. n.i. 6.73 · 107 )
16 20, Female, Ankara n.i. n.i. n.i. n.i. 4.88 · 104 )
CSF, cerebrospinal ﬂuid; TOSV, Toscana virus; n.i., no information.
aIncludes neck rigidity and/or Kernig signs.
bIncludes muscle paresis, alterations of consciousness, tremor and/or cranial nerve involvement.
cIncludes nausea/vomiting (skin rash, lymphadenopathy, hepatic or renal involvement were not observed in any of the cases).
dAs evaluated in serum.
FIG. 2. Phylogenetic trees reconstructed by the neighbour-joining method from (a) partial S-segment sequence (TGCAGgGACACCAT
CACTCTGTCAAGGGTGTCAGCCGCATTTGTTCCGTGGACTGTTCAGGCACTACGTGTCCTGTCAGAATCCCTGCCCGTGTCTGGGACC
ACTATGGATGCCATTGCTGGTGTAACCTACCCAAGAGCCATGATGCACCCA; 153 nt) and (b) L segment sequence (TTGTCAAAAA
TCCCAAAAGTGCTCAGGTCTGAGCTACAAGTATTTCTAACCCACAGGCTATTCAGCACAATGCAGCGAATATCAG; 85 nt). For each
sequence, serotype, strain name and country of isolation are given. Bootstrap values are given in percentages. GenBank accession numbers of the S
segment sequences are HM051104 (Turkish isolate), EF570141.1, GU270841.1, EF570140.1, DQ904354, EU327772.1, DQ975231.1, EF201830.1,
EF201831.1, EF201828.1, EF201832.1, EF201831.1, DQ656078.1, DQ656077.1, EU725773.1, EF201821.1, EF201816.1, EF201817.1, EF201818.1,
AY705943.1, EF120631.2, AY705940.1, AY705938.1, EF120632.1, AY766034, EF201833, EF120630 and DQ656075. GenBank accession numbers of
the L segment sequences are HM151316 (Turkish isolate), X68414, NC_006319, DQ975233, FJ356705, DQ656070, FJ153281, DQ656071,
FJ153279, FJ153280, EF095548, EU725771, EF095551, EU240882, NC_005214.
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Discussion
It is known that in endemic regions, the seroprevalences of
SFVs may be as high as 60%, with frequent multiple infections
[12]. Previous studies on SFV activity in Turkey had identi-
ﬁed human exposures to SFSV, SFNF and TOSV in Aegean
and Mediterranean coastal regions [13,14], but no data
regarding central Anatolia were available. To our knowledge,
this is the largest serosurveillance study from Turkey and
the ﬁrst to identify human SFV exposure in central/northern
Anatolia. In this study, focusing on the central Anatolian
provinces of Ankara, Konya and Eskisehir and the Black Sea
coastal province of Zonguldak, frequent exposure to TOSV
and other SFV serotypes in blood donors was revealed. The
IgG reactivities in IIFT were above 20% for all study regions,
with an overall rate of 32.9% and as high as 65.9% in Konya
(Table 1). Human TOSV exposure was identiﬁed and con-
ﬁrmed by VNT in all regions, with the highest seropreva-
lence observed in Konya (25.5%) followed by Eskisehir,
Ankara and Zonguldak (Table 1). Exposure to the new SFV
serotype SFTV, as identiﬁed by VNT, was observed in Konya
and Ankara and comprised the most frequent serotype in
Konya (28%). SFNV exposure was identiﬁed only in Konya
and SFSV was observed to be present in all regions except
Zonguldak (Table 1). Exposure to multiple SFV serotypes
was detected in Ankara and Konya. These results show that
SFVs are endemic in central Anatolia and must be considered
as the etiologic agent in cases/outbreaks of febrile diseases
with unknown etiology. Also of importance is the detection
of TOSV activity in all regions including the northern Anato-
lian province of Zonguldak, which indicates TOSV as a prob-
able etiologic agent for aseptic meningoencephalitis cases
observed in central/northern Anatolia.
There is only one laboratory-conﬁrmed SFV case from
Turkey, which involves a travel-related SFSV infection pre-
senting as meningitis in a 15-year-old girl, after a vacation in
Turkey [22]. Recently, SFSV and SFTV have been identiﬁed
in outbreaks of febrile diseases with nausea/vomiting in
2007–2008 from the Izmir (Aegean), Adana (Mediterranean)
and Ankara (central Anatolia) regions [15]. In this study, we
have identiﬁed, for the ﬁrst time, acute TOSV CNS infection
by viral RNA detection in 15.7% (16/102) of the aseptic men-
ingitis cases of unidentiﬁed etiology in central Anatolia, Tur-
key. The clinical picture observed in the affected individuals
is consistent with TOSV infections from various endemic
Mediterranean countries, where symptoms of mild meningi-
tis, usually without encephalitic symptoms and with frequent
recovery without sequelae, are common (Table 2) [5,9–12].
We included only RNA-positive individuals as conﬁrmed
TOSV infections because cross-reactions between SFV sero-
types cannot be ruled out in serologic tests and asymptom-
atic infections and/or IgM persistence may result in false-
positive interpretations in endemic regions [1]. Because the
study was performed with previously stored samples, conva-
lescent serum samples were not available for further sero-
logical conﬁrmation. SFV serotypes other than TOSV were
not detected in patients.
It has been suggested that genetically divergent TOSV
strains may co-circulate in endemic regions and at least two
geographically-distinct TOSV populations are present in the
Mediterranean countries [23–25]. The existence of two lin-
eages of TOSV were proposed for Spain and France [24,25].
Phylogenetic analyses of the determined partial S-segment
sequence (153 nt) and partial L-segment sequence (85 nt)
showed highest homologies to TOSV sequences from Italy (S
segment, X53794, NC_006318; L segment, NC006319,
X68414) and France (S segment, DQ975232; L segment,
DQ975233), clearly placing them into group A of TOSV
sequences [23]. Our results also suggest that previously
designed real-time RT-PCR primers targeting the S segment
are effective in identifying acute TOSV infections in Turkey
and can be used in diagnostics [18].
The activity of various species of Phlebotomine sandﬂies
has been observed in Mediterranean, Aegean and central
Anatolian regions in Turkey, including P. papatasi and P. perﬁ-
liewi, well-known vector species for SFVs, but virus charac-
terization has never been accomplished [26,27]. Detailed
entomologic studies are required for displaying viral genomic
heterogeneity in Anatolia.
In conclusion, we have displayed frequent human exposure
to SFVs and the role of TOSV in CNS infections in central/
northern Anatolia. SFVs must be considered as etiologic
agents in cases of febrile diseases and aseptic meningitis in
local residents as well as travellers.
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